Cargando…
“In-Bore” MRI-Guided Prostate Biopsy for Prostate Cancer Diagnosis: Results from 140 Consecutive Patients: Erratum
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785819/ https://www.ncbi.nlm.nih.gov/pubmed/35082579 http://dx.doi.org/10.1097/CU9.0000000000000060 |
Ejemplares similares
-
Imaging of clinically silent rectoprostatic hematoma in MRI guided in-bore prostate biopsy
por: Garmer, Marietta, et al.
Publicado: (2022) -
Patients’ experience with MRI-guided in-bore biopsy versus TRUS-guided biopsy in prostate cancer: a pilot study
por: Pizzoli, Silvia Francesca Maria, et al.
Publicado: (2020) -
Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts
por: Trerotola, Marco, et al.
Publicado: (2015) -
Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome
por: Leach, Damien A., et al.
Publicado: (2015) -
Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks system (Erratum)
por: Sumathipala, Yohan, et al.
Publicado: (2019)